Form 4: GoodRx Officer's Stock Transactions

GoodRx Chief Accounting Officer Romin Nabiey reported the acquisition and disposition of Class A Common Stock related to RSU vesting.

Summary

• Romin Nabiey, Chief Accounting Officer of GoodRx Holdings, Inc. (GDRX), reported stock transactions on August 8, 2025.
• Acquired 12,663 shares of Class A Common Stock through the exercise of Restricted Stock Units (RSUs).
• Disposed of 4,531 shares of Class A Common Stock at a price of $3.47 per share, likely to cover tax liabilities associated with the RSU vesting.
• Following these transactions, direct beneficial ownership of Class A Common Stock is 134,207 shares, and 88,639 Restricted Stock Units remain.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions (RSU vesting and tax-related sale), which are neutral in sentiment and do not indicate significant positive or negative developments for the company.

Positives

• The officer's continued holding of a significant number of shares (134,207 Class A Common Stock and 88,639 RSUs) indicates ongoing alignment with shareholder interests.
• The acquisition of shares through RSU vesting is a routine compensation event, reflecting the company's established executive compensation structure.

Negatives

• The disposition of 4,531 shares, while common for tax purposes, represents a reduction in the officer's direct Class A Common Stock holdings.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• The reported transactions involve an executive (Romin Nabiey) and the company's securities, which are considered related party transactions in the context of insider reporting.

Stakeholder Impact

• Shareholders: Provides transparency on executive stock ownership and compensation practices.
• Employees: Reflects standard executive compensation structures involving equity awards.

Next Steps

• The remaining 93.75% of the Restricted Stock Units will vest in approximately equal quarterly installments over 15 quarters following August 8, 2023.

Key Dates

Keywords

GoodRx, GDRX, SEC Form 4, Insider Trading, Stock Transaction, Restricted Stock Units, RSU, Officer Stock, Romin Nabiey, Chief Accounting Officer